Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
IL-6 promotes cardiac graft rejection mediated by CD4+ cells.
Booth AJ, Grabauskiene S, Wood SC, Lu G, Burrell BE, Bishop DK.
J Immunol. 2011 Dec 1;187(11):5764-71. Epub 2011 Oct 24.
Related citations
IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival.
Turnquist HR, Zhao Z, Rosborough BR, Liu Q, Castellaneta A, Isse K, Wang Z, Lang M, Stolz DB, Zheng XX, Demetris AJ, Liew FY, Wood KJ, Thomson AW.
J Immunol. 2011 Nov 1;187(9):4598-610. Epub 2011 Sep 26.
Blockade of Notch ligand δ1 promotes allograft survival by inhibiting alloreactive Th1 cells and cytotoxic T cell generation.
Riella LV, Ueno T, Batal I, De Serres SA, Bassil R, Elyaman W, Yagita H, Medina-Pestana JO, Chandraker A, Najafian N.
J Immunol. 2011 Nov 1;187(9):4629-38. Epub 2011 Sep 26.
Primary vascularization of the graft determines the immunodominance of murine minor H antigens during organ transplantation.
Kwun J, Malarkannan S, Burlingham WJ, Knechtle SJ.
J Immunol. 2011 Oct 15;187(8):3997-4006. Epub 2011 Sep 7.
IL-7 is required for the development of the intrinsic function of marginal zone B cells and the marginal zone microenvironment.
Willems L, Li S, Rutgeerts O, Lenaerts C, Waer M, Billiau AD.
J Immunol. 2011 Oct 1;187(7):3587-94. Epub 2011 Aug 26.
The novel costimulatory programmed death ligand 1/B7.1 pathway is functional in inhibiting alloimmune responses in vivo.
Yang J, Riella LV, Chock S, Liu T, Zhao X, Yuan X, Paterson AM, Watanabe T, Vanguri V, Yagita H, Azuma M, Blazar BR, Freeman GJ, Rodig SJ, Sharpe AH, Chandraker A, Sayegh MH.
J Immunol. 2011 Aug 1;187(3):1113-9. Epub 2011 Jun 22.
Anticardiac myosin immunity and chronic allograft vasculopathy in heart transplant recipients.
Kalache S, Dinavahi R, Pinney S, Mehrotra A, Cunningham MW, Heeger PS.
J Immunol. 2011 Jul 15;187(2):1023-30. Epub 2011 Jun 15.
EBV-specific CD8+ T cells from asymptomatic pediatric thoracic transplant patients carrying chronic high EBV loads display contrasting features: activated phenotype and exhausted function.
Macedo C, Webber SA, Donnenberg AD, Popescu I, Hua Y, Green M, Rowe D, Smith L, Brooks MM, Metes D.
J Immunol. 2011 May 15;186(10):5854-62. Epub 2011 Apr 1.
Embryonic stem cells, derived either after in vitro fertilization or nuclear transfer, prolong survival of semiallogeneic heart transplants.
Imberti B, Casiraghi F, Cugini D, Azzollini N, Cassis P, Todeschini M, Solini S, Sebastiano V, Zuccotti M, Garagna S, Redi CA, Noris M, Morigi M, Remuzzi G.
J Immunol. 2011 Apr 1;186(7):4164-74. Epub 2011 Mar 9.
Pillars article: long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature. 1996. 381: 434-438. 1996.
Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R, Tucker-Burden C, Cho HR, Aruffo A, Hollenbaugh D, Linsley PS, Winn KJ, Pearson TC.
J Immunol. 2011 Mar 1;186(5):2693-7. No abstract available.
B lymphocytes differentially influence acute and chronic allograft rejection in mice.
DiLillo DJ, Griffiths R, Seshan SV, Magro CM, Ruiz P, Coffman TM, Tedder TF.
J Immunol. 2011 Feb 15;186(4):2643-54. Epub 2011 Jan 19.
CCR5 blockade in combination with cyclosporine increased cardiac graft survival and generated alternatively activated macrophages in primates.
Li J, Chen G, Ye P, Wang S, Zhang K, Chen W, Stepkowski SM, Li J, Zhong S, Xia J.
J Immunol. 2011 Mar 15;186(6):3753-61. Epub 2011 Feb 9.
Transplantation tolerance to a single noninherited MHC class I maternal alloantigen studied in a TCR-transgenic mouse model.
Akiyama Y, Caucheteux SM, Vernochet C, Iwamoto Y, Tanaka K, Kanellopoulos-Langevin C, Benichou G.
J Immunol. 2011 Feb 1;186(3):1442-9. Epub 2010 Dec 22.
Acquisition of humoral transplantation tolerance upon de novo emergence of B lymphocytes.
Parsons RF, Vivek K, Rostami SY, Zekavat G, Ziaie SM, Luo Y, Koeberlein B, Redfield RR, Cancro MP, Naji A, Noorchashm H.
J Immunol. 2011 Jan 1;186(1):614-20. Epub 2010 Nov 17.
Targeted complement inhibitors protect against posttransplant cardiac ischemia and reperfusion injury and reveal an important role for the alternative pathway of complement activation.
Atkinson C, He S, Morris K, Qiao F, Casey S, Goddard M, Tomlinson S.
J Immunol. 2010 Dec 1;185(11):7007-13. Epub 2010 Oct 20.
TIM-3: a novel regulatory molecule of alloimmune activation.
Boenisch O, D'Addio F, Watanabe T, Elyaman W, Magee CN, Yeung MY, Padera RF, Rodig SJ, Murayama T, Tanaka K, Yuan X, Ueno T, Jurisch A, Mfarrej B, Akiba H, Yagita H, Najafian N.
J Immunol. 2010 Nov 15;185(10):5806-19. Epub 2010 Oct 18.
Mechanism and localization of CD8 regulatory T cells in a heart transplant model of tolerance.
Li XL, Ménoret S, Bezie S, Caron L, Chabannes D, Hill M, Halary F, Angin M, Heslan M, Usal C, Liang L, Guillonneau C, Le Mauff B, Cuturi MC, Josien R, Anegon I.
J Immunol. 2010 Jul 15;185(2):823-33. Epub 2010 Jun 11.
CXC chemokine ligand (CXCL) 9 and CXCL10 are antagonistic costimulation molecules during the priming of alloreactive T cell effectors.
Rosenblum JM, Shimoda N, Schenk AD, Zhang H, Kish DD, Keslar K, Farber JM, Fairchild RL.
J Immunol. 2010 Apr 1;184(7):3450-60. Epub 2010 Mar 1.
Immunological property of antibodies against N-glycolylneuraminic acid epitopes in cytidine monophospho-N-acetylneuraminic acid hydroxylase-deficient mice.
Tahara H, Ide K, Basnet NB, Tanaka Y, Matsuda H, Takematsu H, Kozutsumi Y, Ohdan H.
J Immunol. 2010 Mar 15;184(6):3269-75. Epub 2010 Feb 19.
NK cell patrolling and elimination of donor-derived dendritic cells favor indirect alloreactivity.
Garrod KR, Liu FC, Forrest LE, Parker I, Kang SM, Cahalan MD.
J Immunol. 2010 Mar 1;184(5):2329-36. Epub 2010 Feb 5.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on